Research ArticleAccepted Article
Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease
Vanessa L. Kronzer, Weixing Huang, Paul F. Dellaripa, Sicong Huang, Vivi Feathers, Bing Lu, Christine K. Iannaccone, Ritu R. Gill, Hiroto Hatabu, Mizuki Nishino, Cynthia S. Crowson, John M. Davis III, Michael E. Weinblatt, Nancy A. Shadick, Tracy J. Doyle and Jeffrey A. Sparks
The Journal of Rheumatology November 2020, jrheum.200863; DOI: https://doi.org/10.3899/jrheum.200863
Vanessa L. Kronzer
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Weixing Huang
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Paul F. Dellaripa
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Sicong Huang
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Vivi Feathers
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Bing Lu
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Christine K. Iannaccone
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Ritu R. Gill
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Hiroto Hatabu
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Mizuki Nishino
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Cynthia S. Crowson
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
John M. Davis III
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Michael E. Weinblatt
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Nancy A. Shadick
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Tracy J. Doyle
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
Jeffrey A. Sparks
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA; Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA; Division of General Internal Medicine; Brigham and Women’s Hospital; Boston, USA; Department of Radiology; Harvard Medical School, Beth Israel Deaconess Medical Center; Boston, USA; Department of Radiology; Brigham and Women’s Hospital; Boston, USA; Department of Imaging, Dana-Farber Cancer Institute; Boston, USA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA; Division of Pulmonary and Critical Care; Brigham and Women’s Hospital and Harvard Medical School; Boston, USA. Funding: This work was supported by the Rheumatology Research Foundation K Supplement Award; National Institutes of Health [grant numbers K23 AR069688, K23 HL119558, R03 AR075886, R03 HL148484, L30 AR066953, P30 AR070253, and P30 AR072577]; and the R. Bruce and Joan M. Mickey Research Scholar Fund. The Brigham Rheumatoid Arthritis Sequential Study is funded by grants from Bristol-Myers Squibb, Crescendo Bioscience, and Sanofi. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. Corresponding Author: Jeffrey A. Sparks, 60 Fenwood Road Boston, MA 02115. E-mail:jsparks@bwh.harvard.edu
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease
Vanessa L. Kronzer, Weixing Huang, Paul F. Dellaripa, Sicong Huang, Vivi Feathers, Bing Lu, Christine K. Iannaccone, Ritu R. Gill, Hiroto Hatabu, Mizuki Nishino, Cynthia S. Crowson, John M. Davis, Michael E. Weinblatt, Nancy A. Shadick, Tracy J. Doyle, Jeffrey A. Sparks
The Journal of Rheumatology Nov 2020, jrheum.200863; DOI: 10.3899/jrheum.200863
Accepted manuscript
Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease
Vanessa L. Kronzer, Weixing Huang, Paul F. Dellaripa, Sicong Huang, Vivi Feathers, Bing Lu, Christine K. Iannaccone, Ritu R. Gill, Hiroto Hatabu, Mizuki Nishino, Cynthia S. Crowson, John M. Davis, Michael E. Weinblatt, Nancy A. Shadick, Tracy J. Doyle, Jeffrey A. Sparks
The Journal of Rheumatology Nov 2020, jrheum.200863; DOI: 10.3899/jrheum.200863